Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regeneron Pharmaceuticals Inc (REGN)  
$967.98 10.23 (1.05%) as of 4:30 Thu 5/16


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 104,690,000
Market Cap: 101.34(B)
Last Volume: 407,580 Avg Vol: 767,398
52 Week Range: $692.45 - $993.35
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  150
Guru Rank Value     : 6.9
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 14,295 77,700 120,701 282,978
Total Sell Value $13,799,540 $71,512,799 $107,160,703 $220,505,683
Total People Sold 6 13 15 17
Total Sell Transactions 13 37 55 116
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 2410
  Page 1 of 97  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Schleifer Leonard S Bd. Co-Chair, President & CEO   •       •      –    2024-05-15 4 AS $979.05 $10,725,946 D/D (10,941) 397,259     -
   Schleifer Leonard S Bd. Co-Chair, President & CEO   •       •      –    2024-05-14 4 AS $979.16 $24,481,164 D/D (25,000) 408,200     -
   Schleifer Leonard S Bd. Co-Chair, President & CEO   •       •      –    2024-05-13 4 D $976.79 $141,080,710 D/D (144,433) 433,200     -
   Schleifer Leonard S Bd. Co-Chair, President & CEO   •       •      –    2024-05-13 4 OE $399.66 $81,212,511 D/D 203,204 577,633     -
   Sing George L Director   –       •      –    2024-05-03 4 D $942.53 $826,599 D/D (877) 27,472     -
   Sing George L Director   –       •      –    2024-05-03 4 OE $413.33 $826,660 D/D 2,000 28,349     -
   Ryan Arthur F Director   –       •      –    2024-05-01 4 AS $889.50 $89,961 D/D (100) 18,082 8%     
   Mccourt Marion EVP Commercial   •       –      –    2024-05-01 4 AS $889.41 $222,353 D/D (250) 12,931 8%     
   Yancopoulos George Bd. Co-Chair, President & CSO   •       •      –    2024-04-29 4 GA $0.00 $0 I/I 18,148 18,148     -
   Yancopoulos George Bd. Co-Chair, President & CSO   •       •      –    2024-04-29 4 GD $0.00 $0 I/I 36,296 0     -
   Mccourt Marion EVP Commercial   •       –      –    2024-04-01 4 AS $964.73 $241,183 D/D (250) 13,181 0%     
   Ryan Arthur F Director   –       •      –    2024-04-01 4 AS $957.78 $96,253 D/D (100) 18,182 0%     
   Murphy Andrew J EVP Research   •       –      –    2024-03-14 4 AS $951.92 $5,531,290 D/D (5,783) 48,306 2%     
   Murphy Andrew J EVP Research   •       –      –    2024-03-13 4 D $971.82 $13,816,365 D/D (14,217) 54,089     -
   Murphy Andrew J EVP Research   •       –      –    2024-03-13 4 OE $399.66 $7,993,200 D/D 20,000 68,306     -
   Mccourt Marion EVP Commercial   •       –      –    2024-03-01 4 AS $967.50 $346,365 D/D (358) 13,431 -1%     
   Ryan Arthur F Director   –       •      –    2024-03-01 4 AS $967.50 $98,205 D/D (100) 18,282 -1%     
   Sing George L Director   –       •      –    2024-02-26 4 S $990.00 $992,500 D/D (1,000) 26,349 1%     
   Sing George L Director   –       •      –    2024-02-26 4 OE $413.33 $413,330 D/D 1,000 26,849     -
   Stahl Neil EVP Research and Development   •       –      –    2024-02-26 4 GD $0.00 $0 D/D 1,020 50,999     -
   Larosa Joseph J EVP General Counsel and Secret   •       –      –    2024-02-26 4 S $990.00 $990,000 D/D (1,000) 36,543 1%     
   Bassler Bonnie L Director   –       •      –    2024-02-26 4 S $979.25 $836,280 D/D (854) 1,382 1%     
   Bassler Bonnie L Director   –       •      –    2024-02-26 4 OE $391.92 $334,700 D/D 854 2,236     -
   Sing George L Director   –       •      –    2024-02-23 4 S $985.00 $492,500 D/D (500) 26,349 0%     
   Sing George L Director   –       •      –    2024-02-23 4 OE $413.33 $206,665 D/D 500 26,849     -
  2410 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 97
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us